# Pharmacokinetic Evaluation of Moxifloxacin IV to Enteral Switch Therapy in Intensive Care Patients

> **NCT00458900** · PHASE2 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 4 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** IV and enteral administration of moxifloxacin

## Key facts

- **NCT ID:** NCT00458900
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2012-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00458900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00458900, "Pharmacokinetic Evaluation of Moxifloxacin IV to Enteral Switch Therapy in Intensive Care Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00458900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*